TY - JOUR
T1 - Endoscopy
T2 - Fluorescein contrast in confocal laser endomicroscopy
AU - Paramsothy, Sudarshan
AU - Leong, Rupert W. L.
PY - 2010/7
Y1 - 2010/7
N2 - Confocal laser endomicroscopy (CLE) is an emerging technology with important applications in gastrointestinal imaging. Fluorescein, the contrast agent most commonly employed in CLE, has not yet been approved by the FDA for intravenous use with this technique in the gastrointestinal setting. A cross-sectional study suggests that fluorescein is generally safe and usually has none or only mild adverse effects in patients undergoing CLE.
AB - Confocal laser endomicroscopy (CLE) is an emerging technology with important applications in gastrointestinal imaging. Fluorescein, the contrast agent most commonly employed in CLE, has not yet been approved by the FDA for intravenous use with this technique in the gastrointestinal setting. A cross-sectional study suggests that fluorescein is generally safe and usually has none or only mild adverse effects in patients undergoing CLE.
UR - http://www.scopus.com/inward/record.url?scp=77955797423&partnerID=8YFLogxK
U2 - 10.1038/nrgastro.2010.83
DO - 10.1038/nrgastro.2010.83
M3 - Short survey
C2 - 20606632
AN - SCOPUS:77955797423
SN - 1759-5045
VL - 7
SP - 366
EP - 368
JO - Nature Reviews Gastroenterology and Hepatology
JF - Nature Reviews Gastroenterology and Hepatology
IS - 7
ER -